You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Litigation Details for Natural Alternatives International, Inc. v. Creative Compounds, LLC (S.D. Cal. 2016)


✉ Email this page to a colleague

« Back to Dashboard


Natural Alternatives International, Inc. v. Creative Compounds, LLC (S.D. Cal. 2016)

Docket ⤷  Try a Trial Date Filed 2016-08-24
Court District Court, S.D. California Date Terminated 2017-11-29
Cause 28:1391 Venue Assigned To Marilyn L. Huff
Jury Demand Both Referred To Andrew G. Schopler
Parties CORE SUPPLEMENT TECHNOLOGIES, INC.; CREATIVE COMPOUNDS, LLC; DOES 1-100; HONEY BADGER, LLC; MYOPHARMA, INC.; NATURAL ALTERNATIVES INTERNATIONAL, INC.; NELSON NOLTE
Patents RE45,313; RE45,323; RE45,573; RE45,822
Attorneys Caroline C. Maxwell; Frederick William Kosmo , Jr.; Hubert Kim; John K. Buche; Kevin John OShea; Kevin M Bell; Melissa Lynn Bustarde; Micah L. Bailey; Nelson Nolte; Richard J. Oparil; Scott A.M. Chambers; William John McKeague
Firms Buche & Associates, P.C.; Mayfield and Associates; Nolte Law Firm; OShea Law LLC; Porzio, Bromberg & Newman P.C.; Porzio, Bromberg and Newman, PC; Purdy and Bailey; Wilson Petty Kosmo and Turner; Wilson Turner Kosmo LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Natural Alternatives International, Inc. v. Creative Compounds, LLC
The small molecule drug covered by the patents cited in this case is ⤷  Try a Trial .
Biologic Drugs cited in Natural Alternatives International, Inc. v. Creative Compounds, LLC

The biologic drugs covered by the patents cited in this case are ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , and ⤷  Try a Trial .

Details for Natural Alternatives International, Inc. v. Creative Compounds, LLC (S.D. Cal. 2016)

Date Filed Document No. Description Snippet Link To Document
2017-07-19 83 asserting U.S. Patent NO. RE45,947 (“the ‘947 patent”) in the Hi-Tech case but that patent is not asserted…‘084 11 patent”), U.S. Patent No. 7,504,376 (“the ‘376 patent”), and U.S. Patent No. 5,965,596 12 …invalidated the ‘596 patent, the ‘376 patent and the ‘084 16 patent as being directed to patent ineligible subject…five beta-alanine 10 patents owned by NAI. Three of these patents— U.S. Patent No. 7,825,084 (“the ‘084…and 10 of U.S. Patent No. 8,993,610 19 (“the ‘610 patent”). The ‘865 and ‘610 patents are in the same External link to document
2017-08-14 85 that the ‘596, ‘376 and 11 ‘084 patents (and U.S. Patent No. RE45,947, which is not at issue here) were…ICN Pharms., Inc., 313 15 F.Supp.2d 405, 410-11 (D. Del. 2004) (finding patentable weight for functional… five patents – U.S. Patent Nos. 5,965,596 6 (“the ‘596 patent”), 7,504,376 (“the ‘376 patent”), 7,…five NAI patents asserted against Creative here – the ‘596 patent, 8 ‘376 patent, ‘084 patent, ‘610 patent… (“the ‘084 patent”), 7 8,993,610 (“the ‘610 patent”), and 8,470,865 (“the ‘865 patent”). See First External link to document
2017-09-05 89 alleges infringement 12 of U.S. Patent Nos. 5,965,596, 7,825,084, RE45,947, 8,993,610, and 8,470,865. …per day for at least 14 days. 4 U.S. Patent No. RE45,947 at 16:1-11 (filed Mar. 29, 2016). The Court…the ’084 patent, the ’376 patent, the ’596 27 patent, the ’865 patent, and the ’610 patent are invalid…the ’084 patent, the ’947 patent, the ’596 patent, the ’865 patent, and the ’610 patent are invalid…, the ’084 patent, the ’947 patent, the ’376 patent, the ’596 patent, the ’865 10 patent, and the ’ External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.